Sorabenz Tablet
Marketer
Admac Pharma Ltd
Salt Composition
Sorafenib (200mg)
Overview Sorabenz Tablet
Tyrosine kinase inhibitor Sorabenz tablets treat liver, kidney, and thyroid cancers. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's instruction. Common side effects include fatigue, nausea, anorexia, alopecia, and diarrhea. Hypertension is possible; regular blood pressure monitoring is advisable. Report any severe skin reactions (rash), or hand/foot pain, swelling, or redness immediately. Pre-existing heart disease, hepatic or renal impairment, or hypertension must be disclosed before commencement. Inform your healthcare provider of all concurrent medications, as interactions are possible. Sorabenz is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Uses of Sorabenz Tablet
Malignancies affecting the liver, kidneys, and thyroid gland.
Major Benefits of Sorabenz Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sorabenz Tablet on an empty stomach.
Common Side effects of Sorabenz Tablet:
- Fatigue
- Nausea
- Loss of appetite
- Diarrhea
- Abdominal pain
- Hair loss
- Weight loss
- Rash
- Painful blisters on hands and feet
How to use Sorabenz Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sorabenz Tablet on an empty stomach.
How Sorabenz Tablet works:
Sorabenz tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a mutated protein responsible for triggering cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Sorabenz Tablet's interaction with alcohol is undetermined. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Sorabenz Tablet during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Sorabenz Tablet are incompatible. Evidence indicates potential infant toxicity associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Sorabenz Tablet.
KidneySAFE IF PRESCRIBED
Sorabenz tablets are considered safe for patients with kidney impairment; no dosage modification is necessary. Routine blood work monitoring may be prudent during treatment.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Sorabenz Tablet, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Sorabenz Tablet :
Omit any missed Sorabenz Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Sorabenz Tablet
Label | Value |
---|---|
Chemical Category | Diaryl Ether Derivatives |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Behavioral Class | Kinase inhibitors targeting tyrosine |